MB2 Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

MB2 General Information

Description

Developer of a portfolio of drug candidates to treat diabetes and related metabolic diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Primary Office
  • 12406 Horesham Street
  • Carmel, IN 46032
  • United States
+1 (317) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MB2 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 29-Oct-2015 00.00 Completed Startup
1. Early Stage VC 28-Apr-2015 00.00 00.00 Completed Startup
To view MB2’s complete valuation and funding history, request access »

MB2 Patents

MB2 Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2877363-A1 Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function Abandoned 21-Jun-2012 000000000
EP-2863954-A1 Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function Withdrawn 21-Jun-2012 000000000 0
JP-2015531748-A Incretin receptor ligand polypeptide fc region fusion polypeptide and complex having modified fc effector function Abandoned 21-Jun-2012 000000000
US-20140051834-A1 Incretin receptor ligand polypeptide fc-region fusion polypeptides and conjugates with altered fc-effector function Abandoned 21-Jun-2012 C07K16/46 0

MB2 Executive Team (3)

Name Title Board Seat Contact Info
Brad Browning Fitness Professional
Richard DiMarchi Ph.D Co-Founder, Chief Scientific Officer, Board Member & Manager
Kent Hawryluk Co-Founder, Chief Executive Officer & Board Member
To view MB2’s complete executive team members history, request access »

MB2 Board Members (2)

Name Representing Role Since
Kent Hawryluk Self Co-Founder, Chief Executive Officer & Board Member 000 0000
Richard DiMarchi Ph.D MB2 Co-Founder, Chief Scientific Officer, Board Member & Manager 000 0000
To view MB2’s complete board members history, request access »

MB2 Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioCrossroads Venture Capital Minority 000 0000 000000 0
To view MB2’s complete investors history, request access »